Skip to main content

What are the timelines for the Board’s reports, rules, and licensing for participants in the adult-use market?

Submitted by matt.stirnweis… on

Adult-use licensing timeline:  

Act 164 (2020) sets the following timeline for the roll-out of the adult use market:  

  • April 1, 2022: License applications for integrated licensees, small cultivators, and testing laboratories can be accepted.  
  • May 1, 2022: Licenses for integrated licensees, small cultivators, and testing laboratories can begin to be issued.  
    • License applications for all cultivators can also be accepted.  
  • June 1, 2022: Licenses for all cultivators can begin to be issued.  
  • July 1, 2022: License applications for product manufacturers and wholesalers can be accepted.
  • August 1, 2022: Licenses for product manufacturers and wholesalers can begin to be issued.
  • September 1, 2022: License applications for retailers can be accepted.
  • October 1, 2022: Licenses for retailers can begin to be issued.  

Board Rules:  

The Board is in the process of writing rules regulating the adult-use market, as required by Act 164 (2020) and Act 62 (2021). The initial proposed rules will be filed in late 2021. After rules are filed there will be significant opportunity for public input before a rule is finalized. Proposed rules, and information about how to comment on them, will be prominently displayed on the CCB website.  

Reports:  

On October 15, 2021, the Board reported to the legislature regarding recommended fee structure.

On November 1, 2021, the Board reported to the legislature regarding prohibited products, hemp-derived products, and the Medical Cannabis Advisory Panel.  

On January 15, 2022, the Board will report to the legislature regarding:  

  • outreach, training, and employment programs focused on providing economic opportunities to individuals who historically have been disproportionately impacted by cannabis prohibition,
  • online ordering for pick-up or delivery,  
  • additional license types,  
  • cannabidiol minimums, and
  • sale of cannabis-related paraphernalia.